Category: MedtronicSyndicate content

Medtronic's Q4 sales surge 60% on Covidien buy, outlook narrowed

May 19, 2015 by Brad Perriello

Medtronic's fiscal 4th-quarter sales surge nearly 60% thanks to its buyout earlier this year of Covidien, prompting the medical device company to tighten its earning forecast.

Medtronic's Q4 sales surge 60% on Covidien buy, outlook raised

Appeals court denies en banc review of Medtronic InFuse suit

May 18, 2015 by Fink Densford

A federal appeals court will not re-hear a decision dismissing a lawsuit filed over the alleged off-label use of Medtronic’s InFuse bone-growth protein.

Appeals court denies en banc review of Medtronic InFuse lawsuit

HRS 2015: Good data for Medtronic's Micra leadless pacemaker

May 15, 2015 by Brad Perriello

Medtronic's Micra leadless pacemaker passes the initial safety and efficacy endpoints at the 1-month mark of a global clinical trial.

HRS 2015: Good data for Medtronic's Micra leadless pacemaker

HRS 2015: Cryoablation as good as standard ablation for AF

May 14, 2015 by Fink Densford

Data from a new study shows the noninferiority of cryoablation to standard ablation treatments for paroxysmal atrial fibrillation.

HRS 2015: Cryoablation as effective as radio frequency ablation

Cryoablation is as effective as radio-frequency ablation in treating paroxysmal atrial fibrillations, researchers reported today at the Heart Rhythm Society’s annual meeting in Boston.

HRS 2015: Medtronic's MRI-safe Evera ICD passes 1st randomized trial

May 14, 2015 by Brad Perriello

Medtronic's Evera MRI SureScan implantable cardioverter defibrillator meets the safety and efficacy endpoints of the 1st randomized trial of an MRI-safe ICD.

HRS 2015: Medtronic's MRI-safe Evera ICD passes 1st randomized safety trial

Medtronic's Arctic Front Advance ST wins FDA approval

May 12, 2015 by Fink Densford

The newest version of Medtronic's Arctic Front cryoballoon has won approval for use in treatment of paroxysmal atrial fibrillation.

Medtronic's Arctic Front Advance ST wins FDA approval

Medtronic (NYSE:MDT) said it won FDA approval for its Arctic Front Advance ST cryoablation catheter for treating atrial fibrillation, touting a 40% shorter tip than previous versions.

FDA pulls older guidance documents | Regulatory news for the week of May 11, 2015

May 12, 2015 by MassDevice

Here's a look at some of the top regulatory stories for medical device companies this week: FDA withdraws older guidance documents; Medtech panel: Good news-bad news on FDA, value-based healthcare; Medtronic launches new spine devices; FDA warns Smith & Nephew on Truclear Ultra morcellator; FDA clears Medtronic's Euphora balloon

FDA withdraws older guidance documents

May 6, 2015 by Mark Hollmer

FDA withdraws older guidance documents